Procter & Gamble Executive Sells Shares to Cover Tax Obligation
Procter & Gamble’s Paul Gama, the CEO of Health Care, sold 2,225 shares of the company’s common stock on October 5, 2026, at a price of $145.34 per share. The sale was made to cover a tax obligation arising from the settlement of a Restricted Stock Unit (RSU) award. After the transaction, Gama directly held 51,124 shares, with an additional 1,184 shares held indirectly through the Retirement Plan Trustee, reflecting an adjustment through September 30, 2026.
A Restricted Stock Unit award is a company promise to grant an employee a specified number of shares in the future, contingent on meeting certain conditions like employment tenure or performance goals. These awards can affect the total number of outstanding shares and align employee incentives with shareholder interests.
The SEC filing also noted that there was no Rule 10b5-1 plan reported. This plan is a prearranged trading schedule that allows insiders to buy or sell shares at set times, reducing the risk of insider trading accusations.
The total value of the shares sold by Gama amounted to $323,000. The transaction was reported in a Form 4 filing with the SEC on October 6, 2026.